How should ketamine be dosed intraoperatively as part of a multimodal analgesic regimen, including bolus and infusion rates, adjustments for elderly or frail patients, contraindications, and alternative adjuncts?

Intraoperative Ketamine Dosing for Multimodal Analgesia

For intraoperative multimodal analgesia, administer ketamine as a 0.5 mg/kg IV bolus after induction, followed by a continuous infusion of 0.1-0.25 mg/kg/h (maximum 0.4 mg/kg/h), stopping 30 minutes before the end of surgery to prevent psychodysleptic effects. 1

Standard Adult Dosing Protocol

Initial Bolus

• Dose: 0.5 mg/kg IV administered slowly over 60 seconds after anesthesia induction 1, 2
• Timing: Give after induction to minimize emergence reactions and psychodysleptic side effects 1
• Rationale: Rapid administration causes respiratory depression and enhanced vasopressor response 2

Maintenance Infusion

• Standard rate: 0.125-0.25 mg/kg/h continuous infusion 1
• Maximum rate: 0.4 mg/kg/h 3
• Duration: Continue until 30 minutes before end of surgery 1
• Alternative: 0.1-0.5 mg/minute microdrip infusion for maintenance 2

S-Ketamine Adjustments

When using S-ketamine (the more potent enantiomer), reduce the bolus dose to 0.25-0.5 mg/kg 3. The infusion rates remain similar, though clinical judgment should guide dosing at the lower end of the range.

Pediatric Dosing

For children, the dosing mirrors adult protocols:

• Bolus: 0.5 mg/kg IV (reduce to 0.25-0.5 mg/kg for S-ketamine) 3
• Infusion: 0.1-0.2 mg/kg/h (maximum 0.4 mg/kg/h) 3
• PACU breakthrough pain: 0.5 mg/kg IV, titrated to effect (0.25-0.5 mg/kg for S-ketamine) 3

Elderly and Frail Patient Modifications

The evidence does not provide specific dose reductions for elderly or frail patients. However, applying general anesthetic principles:

• Start at the lower end of the dosing range (0.25-0.3 mg/kg bolus, 0.1 mg/kg/h infusion)
• Titrate slowly and monitor hemodynamic response closely
• Consider cardiovascular contraindications more carefully (see below)
• Be vigilant for CNS adverse effects, though these occur in only 5% of patients receiving ketamine versus 4% with placebo 4

The PODCAST trial included patients over 60 years undergoing major surgery and found no increased delirium risk with ketamine (19.45% vs 19.82% placebo) 5, suggesting reasonable safety in older populations when dosed appropriately.

Clinical Indications for Ketamine

Prioritize ketamine use in two specific situations 1:

1. Surgery with high risk of acute or chronic postoperative pain (major abdominal, thoracic, orthopedic procedures)
2. Patients with vulnerability to pain, particularly:
   • Chronic opioid users
   • Opioid-dependent patients
   • Patients with opioid tolerance

The evidence shows ketamine reduces opioid consumption by approximately 40% 6, with an 8 mg morphine equivalent reduction at 24 hours and 13 mg at 48 hours 4. Pain scores decrease by 5/100 mm on VAS at both 24 and 48 hours 4.

Absolute Contraindications

Do not use ketamine in patients with 2:

• Conditions where significant blood pressure elevation would be hazardous (uncontrolled hypertension, stroke, intracranial mass, increased intracranial pressure)
• Active psychosis or schizophrenia
• Acute angle-closure glaucoma

Critical Administration Requirements

Preparation and Dilution

• 100 mg/mL concentration must be diluted before IV use 2
• Dilute with equal volume of sterile water, normal saline, or D5W
• For maintenance infusion: prepare 1 mg/mL solution (10 mL of 50 mg/mL in 500 mL carrier)
• Use immediately after dilution 2

Monitoring and Safety

• Administer only with experienced anesthesia provider present 2
• Emergency airway equipment must be immediately available 2
• Continuously monitor vital signs 2
• Give antisialagogue prior to induction due to salivation risk 2
• Augment with benzodiazepine to prevent neuropsychological emergence phenomena 2

Timing Considerations

The evidence strongly supports continuous infusion over single bolus 7. A study comparing administration methods found that perioperative and postoperative 48-hour ketamine infusion significantly reduced morphine consumption, while preoperative single bolus or intraoperative-only infusion did not 7. However, for practical intraoperative use, the bolus-plus-infusion approach (stopping 30 minutes before surgery end) represents the guideline-recommended compromise 1.

Common Pitfalls to Avoid

1. Do not continue ketamine into the postoperative period routinely - this increases hallucination risk without substantially improving analgesia 1
2. Do not give rapid IV bolus - administer over 60 seconds minimum to prevent respiratory depression 2
3. Do not use 100 mg/mL concentration IV without dilution - this is explicitly contraindicated 2
4. Do not assume dose-dependent efficacy - higher doses (0.6 mg/kg/h) show no advantage over lower doses (0.12 mg/kg/h) and cause more sedation 8
5. Do not withhold in patients with respiratory depression concerns - one study showed 15 patients developed respiratory depression before ketamine administration, but none after 9

Alternative Adjuncts

When ketamine is contraindicated or unavailable, consider these alternatives as part of multimodal analgesia 3, 1:

• IV lidocaine: 1.5 mg/kg bolus, then 1.5 mg/kg/h infusion (adults); 1.5 mg/kg bolus, then 1.5 mg/kg/h in children 3, 1
• Dexmedetomidine: 0.5-1 mcg/kg bolus in adults; 1-3 mcg/kg bolus with 0.2-0.7 mcg/kg/h infusion in children 3
• Dexamethasone: 8 mg IV in adults; 0.15-0.25 mg/kg (max 0.5 mg/kg) in children 3, 1
• Magnesium: Not currently recommended due to insufficient evidence 1
• Gabapentinoids: Not recommended for routine preoperative use 1

Adverse Event Profile

CNS adverse events occur in 5% of ketamine patients versus 4% of controls (RR 1.2,95% CI 0.95-1.4) 4, representing no clinically significant increase. Ketamine actually reduces postoperative nausea and vomiting from 27% to 23% (NNT = 24) 4. The risk of emergence reactions is minimized by administering the bolus after induction and stopping the infusion 30 minutes before surgery completion 1.

For chronic ketamine use (off-label indications), genitourinary pain has been reported 2, but this is not relevant to single-procedure intraoperative use.